SQUAMOUS CELL CARCINOMA OF THE ANUS
Clinical trials for SQUAMOUS CELL CARCINOMA OF THE ANUS explained in plain language.
Never miss a new study
Get alerted when new SQUAMOUS CELL CARCINOMA OF THE ANUS trials appear
Sign up with your email to follow new studies for SQUAMOUS CELL CARCINOMA OF THE ANUS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Blood test could guide anal cancer treatment, reducing side effects
Disease control Recruiting nowThis study tests whether a blood test (ctDNA) can help doctors customize the dose of chemoradiation for people with anal cancer. Depending on how the tumor responds, some patients may get a lower radiation dose to reduce side effects, while others may get a higher dose or an adde…
Matched conditions: SQUAMOUS CELL CARCINOMA OF THE ANUS
Phase: PHASE2 • Sponsor: Jennifer Dorth • Aim: Disease control
Last updated Aug 16, 2026 00:00 UTC
-
New liposomal drug takes on advanced cancers
Disease control Recruiting nowThis study tests an experimental drug called SMP-3124LP, which is a liposomal (fat-encapsulated) version of a cancer-fighting compound. It is for adults with advanced solid tumors that have not responded to standard treatments. The trial has two parts: first, finding the safest d…
Matched conditions: SQUAMOUS CELL CARCINOMA OF THE ANUS
Phase: PHASE1, PHASE2 • Sponsor: Sumitomo Pharma America, Inc. • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
New drug IDP-001 takes on advanced cancers in early trial
Disease control Recruiting nowThis study tests an experimental drug called IDP-001 in people with advanced or metastatic solid tumors, including certain lung, head and neck, and other cancers. The trial has two phases: first to check safety and find the right dose, then to see if the drug can shrink tumors. A…
Matched conditions: SQUAMOUS CELL CARCINOMA OF THE ANUS
Phase: PHASE1, PHASE2 • Sponsor: InduPro, Inc. • Aim: Disease control
Last updated Jul 31, 2026 00:00 UTC
-
New drug combo shows promise for early anal cancer
Disease control Recruiting nowThis study tests whether adding the immunotherapy drug pembrolizumab to standard chemotherapy and radiation can improve outcomes for people with early-stage anal cancer. About 23 participants will receive the combination treatment, followed by maintenance therapy. The main goal i…
Matched conditions: SQUAMOUS CELL CARCINOMA OF THE ANUS
Phase: PHASE2 • Sponsor: Dustin Deming • Aim: Disease control
Last updated Jul 30, 2026 00:00 UTC